166 related articles for article (PubMed ID: 31852291)
1. Pharmacokinetics, tissue distribution and safety of gold nanoparticle/PKC Delta inhibitor peptide hybrid in rats.
Konoeda H; Takizawa H; Gower A; Zhao M; Adeyi OA; Liu M
Nanotoxicology; 2020 Apr; 14(3):341-354. PubMed ID: 31852291
[TBL] [Abstract][Full Text] [Related]
2. Protein Kinase C-delta Inhibitor Peptide Formulation using Gold Nanoparticles.
Konoeda H; Yang H; Yang C; Gower A; Xu C; Zhang W; Liu M
J Vis Exp; 2019 Mar; (145):. PubMed ID: 30907873
[TBL] [Abstract][Full Text] [Related]
3. Effective delivery of a rationally designed intracellular peptide drug with gold nanoparticle-peptide hybrids.
Lee D; Zhao J; Yang H; Xu S; Kim H; Pacheco S; Keshavjee S; Liu M
Nanoscale; 2015 Aug; 7(29):12356-60. PubMed ID: 26151444
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticles alter parameters of oxidative stress and energy metabolism in organs of adult rats.
Ferreira GK; Cardoso E; Vuolo FS; Michels M; Zanoni ET; Carvalho-Silva M; Gomes LM; Dal-Pizzol F; Rezin GT; Streck EL; Paula MM
Biochem Cell Biol; 2015 Dec; 93(6):548-57. PubMed ID: 26583437
[TBL] [Abstract][Full Text] [Related]
5. Quantitative biokinetics and systemic translocation of various gold nanostructures are highly dependent on their size and shape.
Zhang J; Nie X; Ji Y; Liu Y; Wu X; Chen C; Fang X
J Nanosci Nanotechnol; 2014 Jun; 14(6):4124-38. PubMed ID: 24738361
[TBL] [Abstract][Full Text] [Related]
6. Surface chemistry governs the sub-organ transfer, clearance and toxicity of functional gold nanoparticles in the liver and kidney.
Li X; Wang B; Zhou S; Chen W; Chen H; Liang S; Zheng L; Yu H; Chu R; Wang M; Chai Z; Feng W
J Nanobiotechnology; 2020 Mar; 18(1):45. PubMed ID: 32169073
[TBL] [Abstract][Full Text] [Related]
7. Enhanced intracellular translocation and biodistribution of gold nanoparticles functionalized with a cell-penetrating peptide (VG-21) from vesicular stomatitis virus.
Tiwari PM; Eroglu E; Bawage SS; Vig K; Miller ME; Pillai S; Dennis VA; Singh SR
Biomaterials; 2014 Nov; 35(35):9484-94. PubMed ID: 25154664
[TBL] [Abstract][Full Text] [Related]
8. Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide.
Chen YS; Hung YC; Lin WH; Huang GS
Nanotechnology; 2010 May; 21(19):195101. PubMed ID: 20400818
[TBL] [Abstract][Full Text] [Related]
9. Overendocytosis of gold nanoparticles increases autophagy and apoptosis in hypoxic human renal proximal tubular cells.
Ding F; Li Y; Liu J; Liu L; Yu W; Wang Z; Ni H; Liu B; Chen P
Int J Nanomedicine; 2014; 9():4317-30. PubMed ID: 25246788
[TBL] [Abstract][Full Text] [Related]
10. Gold Nanoparticles Conjugated with Glycopeptides for Lectin Detection and Imaging on Cell Surface.
Tsutsumi H; Shirai T; Ohkusa H; Mihara H
Protein Pept Lett; 2018; 25(1):84-89. PubMed ID: 29256341
[TBL] [Abstract][Full Text] [Related]
11. Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide.
Guerrero S; Araya E; Fiedler JL; Arias JI; Adura C; Albericio F; Giralt E; Arias JL; Fernández MS; Kogan MJ
Nanomedicine (Lond); 2010 Aug; 5(6):897-913. PubMed ID: 20735225
[TBL] [Abstract][Full Text] [Related]
12. The enhanced longevity and liver targetability of Paclitaxel by hybrid liposomes encapsulating Paclitaxel-conjugated gold nanoparticles.
Bao QY; Zhang N; Geng DD; Xue JW; Merritt M; Zhang C; Ding Y
Int J Pharm; 2014 Dec; 477(1-2):408-15. PubMed ID: 25455782
[TBL] [Abstract][Full Text] [Related]
13. Gold nanoparticles administration induces disarray of heart muscle, hemorrhagic, chronic inflammatory cells infiltrated by small lymphocytes, cytoplasmic vacuolization and congested and dilated blood vessels.
Abdelhalim MA
Lipids Health Dis; 2011 Dec; 10():233. PubMed ID: 22151883
[TBL] [Abstract][Full Text] [Related]
14. Amoxicillin functionalized gold nanoparticles reverts MRSA resistance.
Kalita S; Kandimalla R; Sharma KK; Kataki AC; Deka M; Kotoky J
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():720-7. PubMed ID: 26838902
[TBL] [Abstract][Full Text] [Related]
15. In vivo tumor targeting of gold nanoparticles: effect of particle type and dosing strategy.
Puvanakrishnan P; Park J; Chatterjee D; Krishnan S; Tunnell JW
Int J Nanomedicine; 2012; 7():1251-8. PubMed ID: 22419872
[TBL] [Abstract][Full Text] [Related]
16. Gold nanoparticles in ophthalmology.
Masse F; Ouellette M; Lamoureux G; Boisselier E
Med Res Rev; 2019 Jan; 39(1):302-327. PubMed ID: 29766541
[TBL] [Abstract][Full Text] [Related]
17. Gold Nanoparticle Toxicity in Mice and Rats: Species Differences.
Bahamonde J; Brenseke B; Chan MY; Kent RD; Vikesland PJ; Prater MR
Toxicol Pathol; 2018 Jun; 46(4):431-443. PubMed ID: 29742986
[TBL] [Abstract][Full Text] [Related]
18. The biodistribution and pharmacokinetic evaluation of choline-bound gold nanoparticles in a human prostate tumor xenograft model.
Razzak R; Zhou J; Yang X; Pervez N; Bédard EL; Moore RB; Shaw A; Amanie J; Roa WH
Clin Invest Med; 2013 Jun; 36(3):E133-42. PubMed ID: 23739667
[TBL] [Abstract][Full Text] [Related]
19. Enhanced and selective permeability of gold nanoparticles functionalized with cell penetrating peptide derived from maurocalcine animal toxin.
Khamehchian S; Nikkhah M; Madani R; Hosseinkhani S
J Biomed Mater Res A; 2016 Nov; 104(11):2693-700. PubMed ID: 27324825
[TBL] [Abstract][Full Text] [Related]
20. Biokinetics of ultrafine gold nanoparticles (AuNPs) relating to redistribution and urinary excretion: a long-term in vivo study.
Naz F; Koul V; Srivastava A; Gupta YK; Dinda AK
J Drug Target; 2016 Sep; 24(8):720-9. PubMed ID: 26837799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
